PMGC Holdings(ELAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ELAB PMGC Holdings

盘前交易 04-01 04:24:11 EDT

5.99

+2.43

+68.26%

盘前7.89

+1.90+31.72%

04:24 EDT

最高6.50	最低3.52	成交量5,705万
今开3.95	昨收3.56	日振幅83.71%
总市值694.31万	流通市值322.62万	总股本115.91万
成交额2.77亿	换手率10,592.39%	流通股本53.86万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":5.99,"timestamp":1774987200000,"preClose":3.56,"halted":0,"volume":57050637,"hourTrading":{"tag":"盘前","latestPrice":7.89,"preClose":5.99,"latestTime":"04:24 EDT","volume":312097,"amount":2534351.5425090003,"timestamp":1775031851262,"change":1.9,"changeRate":0.317195,"amplitude":0.153589},"delay":0,"changeRate":0.6825842696629214,"floatShares":538600,"shares":1159112,"eps":-572.8505,"marketStatus":"盘前交易","change":2.43,"latestTime":"04-01 04:24:11 EDT","open":3.95,"high":6.4999,"low":3.52,"amount":276688372.5444195,"amplitude":0.837051,"askPrice":7.91,"askSize":42,"bidPrice":7.86,"bidSize":63,"shortable":3,"etf":0,"ttmEps":-572.8505,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775050200000},"marketStatusCode":1,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":5.99,"preHourTrading":{"tag":"盘前","latestPrice":7.89,"preClose":5.99,"latestTime":"04:24 EDT","volume":312097,"amount":2534351.5425090003,"timestamp":1775031851262,"change":1.9,"changeRate":0.317195,"amplitude":0.153589},"postHourTrading":{"tag":"盘后","latestPrice":7.65,"preClose":5.99,"latestTime":"19:59 EDT","volume":14426045,"amount":110116612.5464,"timestamp":1775001599620,"change":1.66,"changeRate":0.277129,"amplitude":0.539232},"volumeRatio":1.7932173989368978},"requestUrl":"/m/hq/s/ELAB","defaultTab":"news","newsList":[{"id":"1164291688","title":"PMGC Holdings [纳斯达克: ELAB] 公布2025年度业绩并提交10-K表格，公司资产规模扩大至1380万美元，较2024年增长43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164291688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164291688?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:05","pubTimestamp":1774868717,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc.（纳斯达克代码：ELAB）正式披露2025财年完整年度财务报告，并向美国证券交易委员会提交Form 10-K文件。最新数据显示，公司总资产规模已攀升至1380万美元，较2024年同期实现43%的显著增长。\n此次资产规模的扩张印证了公司战略布局的有效性。通过优化资源配置与精准投资，PMGC Holdings在竞争激烈的市场环境中持续强化财务基础。10-K文件的提交进一步增强了企业透明度，为投资者提供更全面的决策依据。\n（注：原文中重复的标题信息已整合为连贯的正文内容）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132477234","title":"Northstrive Biosciences与Moa Life Plus签署许可协议修正案，共同开发靶向肌肉保留的双重肌肉生长抑制素资产，以联合GLP-1疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1132477234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132477234?lang=zh_cn&edition=full","pubTime":"2026-03-28 04:06","pubTimestamp":1774641974,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences已与Moa Life Plus [Kosdaq: 142760]签署了一项许可协议修正案。此次合作的核心在于共同开发靶向肌肉保留的双重肌肉生长抑制素资产，旨在将其与GLP-1疗法结合使用。这一举措有望为相关治疗领域带来新的协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159921822","title":"SVM Machining公司成功获得ITAR注册资质，正式进军美国国防制造合同领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1159921822","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159921822?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:07","pubTimestamp":1774350477,"startTime":"0","endTime":"0","summary":"SVM Machining公司近日已正式获得国际武器贸易条例（ITAR）注册认证。这一重要资质使该公司有资格参与美国国防制造领域的合同项目，为其业务拓展打开了新的战略通道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165017829","title":"Northstrive Biosciences启动El-32临床前研究，评估GLP-1减重疗法中的肌肉保护作用","url":"https://stock-news.laohu8.com/highlight/detail?id=1165017829","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165017829?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:31","pubTimestamp":1773142289,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences公司宣布，正式启动其候选药物El-32的临床前研究。该研究旨在评估El-32在GLP-1受体激动剂类减重疗法中，对于肌肉组织的保护功效。随着GLP-1药物在体重管理领域的广泛应用，如何有效防止治疗过程中可能伴随的肌肉流失，已成为行业关注的焦点。此次研究的启动，标志着Northstrive Biosciences在探索减重疗法优化方案方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128622806","title":"Northstrive Biosciences签署最终许可协议，推进肌肉抑制素工程益生菌El-22与El-32在动物健康领域的商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1128622806","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128622806?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:30","pubTimestamp":1770813014,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences公司已正式签署一项最终许可协议，旨在推动其创新产品El-22与El-32的商业化应用。这两种产品是基于肌肉抑制素（Myostatin）工程改造的益生菌，专门用于动物健康领域的肌肉维持，标志着该技术在畜牧与伴侣动物营养管理方面迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195857161","title":"PMGC Holdings旗下Northstrive Biosciences与Modulant Biosciences达成许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1195857161","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195857161?lang=zh_cn&edition=full","pubTime":"2026-02-11 05:41","pubTimestamp":1770759682,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc（股票代码：ELAB）宣布，其子公司Northstrive Biosciences已与Modulant Biosciences签署许可协议。该协议于近日通过美国证券交易委员会（SEC）文件正式披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603967188","title":"Pmgc Holdings Inc.盘中异动 股价大跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603967188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603967188?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:42","pubTimestamp":1768401764,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日22时42分，Pmgc Holdings Inc.股票出现波动，股价大幅下挫6.09%。截至发稿，该股报3.78美元/股，成交量5.1316万股，换手率4.33%，振幅6.47%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114224244a71ab023&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114224244a71ab023&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146191982","title":"PMGC Holdings宣布战略性入股微型模块化反应堆（MMR）核能公司Nuclea Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=1146191982","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146191982?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:30","pubTimestamp":1767702630,"startTime":"0","endTime":"0","summary":"PMGC Holdings近日公布了一项战略性股权收购计划，目标锁定专注于微型模块化反应堆技术的核能企业Nuclea Energy。此次入股标志着PMGC Holdings在清洁能源领域的战略布局进一步深化。通过本次交易，PMGC Holdings将获得Nuclea Energy的显著股权地位，为双方在先进核能技术研发与商业化应用方面奠定合作基础。这一战略举措不仅强化了PMGC Holdings在新能源产业链的参与度，也展现出其对创新能源技术长期价值的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592790537","title":"Pmgc Holdings Inc.盘中异动 早盘大幅下跌9.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592790537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592790537?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:30","pubTimestamp":1765981806,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时30分，Pmgc Holdings Inc.股票出现波动，股价快速下跌9.59%。截至发稿，该股报2.97美元/股，成交量748.795万股，换手率1006.30%，振幅0.00%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Zymeworks Inc.、Zevra Therapeutics, Inc.、Zura Bio Limited涨幅较大，Pmgc Holdings Inc.、Aditxt, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1006.30%、740.48%、224.76%，振幅较大的相关个股有Cybin Inc.、Theriva Biologics, Inc.、Voyager Therapeutics, Inc.，振幅分别为2.25%、1.45%、1.13%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217223006a4575ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217223006a4575ddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159697458","title":"PMGC Holdings Inc. [Nasdaq: ELAB] 祝贺 General Enterprise Ventures, Inc. [Nyse: CITR] 上市到 Nyse American，强调股份权益","url":"https://stock-news.laohu8.com/highlight/detail?id=1159697458","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159697458?lang=zh_cn&edition=full","pubTime":"2025-12-04 23:59","pubTimestamp":1764863951,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc. [Nasdaq: ELAB] 祝贺 General Enterprise Ventures, Inc. [Nyse: CITR] 上市到 Nyse American，强调股份权益","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100430737","title":"PMGC Holdings子公司Aga Precision Systems收购Indarg Engineering，拓展航天与国防制造平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1100430737","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100430737?lang=zh_cn&edition=full","pubTime":"2025-10-28 20:01","pubTimestamp":1761652873,"startTime":"0","endTime":"0","summary":"PMGC Holdings子公司Aga Precision Systems完成对Indarg Engineering的收购，进一步拓展其航天与国防制造平台。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166294","title":"Pmgc Holdings Inc.股价重挫31.30% 市值跌106.92万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166294?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271521,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Pmgc Holdings Inc.股票出现异动，股价急速下挫31.30%。截至发稿，该股报0.845美元/股，成交量25.9526万股，换手率6.42%，振幅3.72%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223201abeb77aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223201abeb77aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2517960624","title":"Pmgc Holdings Inc.盘中异动 大幅下挫5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517960624?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:11","pubTimestamp":1741104710,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时11分，Pmgc Holdings Inc.股票出现波动，股价快速下挫5.37%。截至发稿，该股报1.15美元/股，成交量6.1121万股，换手率1.51%，振幅5.04%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1191.25%、1160.29%、778.87%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为117.24%、66.67%、66.02%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305001150abe80a9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305001150abe80a9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376837","title":"Pmgc Holdings Inc.盘中异动 股价大涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376837?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:32","pubTimestamp":1740756740,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时32分，Pmgc Holdings Inc.股票出现波动，股价大幅上涨5.04%。截至发稿，该股报1.25美元/股，成交量3.8929万股，换手率0.96%，振幅4.97%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233220abe0f927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228233220abe0f927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514339134","title":"Pmgc Holdings Inc.盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514339134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514339134?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:03","pubTimestamp":1740683013,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时03分，Pmgc Holdings Inc.股票出现异动，股价快速跳水5.20%。截至发稿，该股报1.19美元/股，成交量11.5632万股，换手率2.86%，振幅7.24%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1883.11%、321.82%、151.80%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228030334a256b7a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228030334a256b7a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514739859","title":"Pmgc Holdings Inc.盘中异动 股价大涨5.79%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514739859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514739859?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:04","pubTimestamp":1740582279,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时04分，Pmgc Holdings Inc.股票出现异动，股价大幅上涨5.79%。截至发稿，该股报1.28美元/股，成交量14.6887万股，换手率3.63%，振幅7.44%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4668.95%、160.88%、144.77%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为155.93%、39.47%、29.31%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623043996315602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623043996315602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514409057","title":"Pmgc Holdings Inc.股价重挫15.92% 市值跌84.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514409057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514409057?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493931,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Pmgc Holdings Inc.股票出现异动，股价大幅跳水15.92%。截至发稿，该股报1.32美元/股，成交量6.1852万股，换手率1.53%，振幅1.15%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为750.39%、464.82%、230.81%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.，振幅分别为20.51%、14.67%、8.87%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223211a25386f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223211a25386f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513551778","title":"Pmgc Holdings Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513551778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513551778?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Pmgc Holdings Inc.股票出现异动，股价大幅下挫5.15%。截至发稿，该股报1.57美元/股，成交量5.2013万股，换手率1.29%，振幅6.06%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为161.52%、71.01%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230507abdb1630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230507abdb1630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166835000","title":"“减脂不减肌”：药企竞逐下一代减肥药新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1166835000","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166835000?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:58","pubTimestamp":1740045485,"startTime":"0","endTime":"0","summary":"罗氏计划今年启动中期试验，将其与自研GLP-1减肥候选药CT-388联用。BiohavenBiohaven在一项早期肥胖试验中评估其靶向肌肉生长抑制素的药物taldefgrobep alfa。该药虽未改善脊髓性肌萎缩症患者的运动功能，但减少了总体脂肪量，并在去脂体重和骨密度方面优于安慰剂。公司将在男性肥胖患者的早期研究中评估安全性，数据预计2025年一季度公布。","market":"us","thumbnail":"https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“减脂不减肌”：药企竞逐下一代减肥药新突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KROS","SRRK","ARWR","VERU","REGN","RHHBY","AZN","ELAB","LLY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2510861328","title":"Pmgc Holdings Inc.盘中异动 股价大跌5.32%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510861328?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:17","pubTimestamp":1739200668,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时17分，Pmgc Holdings Inc.股票出现波动，股价快速跳水5.32%。截至发稿，该股报1.78美元/股，成交量9.8494万股，换手率3.21%，振幅5.59%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231748961e09e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231748961e09e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4183","ELAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pmgcholdings.com","stockEarnings":[{"period":"1week","weight":1.0727},{"period":"1month","weight":-0.1611},{"period":"3month","weight":-0.8314},{"period":"6month","weight":-0.9541},{"period":"1year","weight":-0.9846},{"period":"ytd","weight":-0.8314}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.052},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0282},{"period":"1year","weight":0.1626},{"period":"ytd","weight":-0.0463}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PMGC Holdings Inc.于2020年6月9日根据特拉华州法律成立。2024年12月23日，重组包括将公司名称从Elevai Labs Inc.更改为PMGC Holdings Inc.，并将公司地址从特拉华州迁至内华达州。该公司是一家由医生提供的护肤品公司，专注于使美感护肤品现代化。该公司进行研发，以推进创新和科学驱动的局部护肤，补充医疗美容行业。自2022年以来，该公司主要采用企业对企业的模式，生产和商业化新一代局部护肤产品，其中包含专为改善皮肤外观而设计的专有干细胞衍生的Elevai ExosomesTM。","exchange":"NASDAQ","name":"PMGC Holdings","nameEN":"PMGC Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PMGC Holdings(ELAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PMGC Holdings(ELAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PMGC Holdings,ELAB,PMGC Holdings股票,PMGC Holdings股票老虎,PMGC Holdings股票老虎国际,PMGC Holdings行情,PMGC Holdings股票行情,PMGC Holdings股价,PMGC Holdings股市,PMGC Holdings股票价格,PMGC Holdings股票交易,PMGC Holdings股票购买,PMGC Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PMGC Holdings(ELAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PMGC Holdings(ELAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}